— Accelerating the Deployment of AI-Driven Life Science Solutions in the Indian Market —
TOKYO, Japan — CarbGeM Inc. (Headquarters: Shibuya-ku, Tokyo; CEO: Masakazu Nakajima; hereinafter “CarbGeM”), a developer of AI-powered life science solutions, is pleased to announce the signing of a Memorandum of Understanding (MOU) with DSS Imagetech Pvt. Ltd. (Headquarters: New Delhi, India; hereinafter “DSS”), a leading player in medical and research imaging equipment, to expand its AI business in the Indian market.
CarbGeM was recently selected as one of the “Top 10” startups—and the only Japanese company among them—at the “AI Impact Summit 2026” hosted by the Government of India. Selected from over 4,650 applicants across more than 60 countries, CarbGeM’s AI technology was recognized for its significant social impact in the field of healthcare diagnostics. This achievement underscores the direct potential of our AI technology to address global health challenges. (Award Details: https://carbgem.com/en/news-20260218-en/ )
This MOU represents a major step toward scaling the real-world deployment of our acclaimed AI technology in India. By leveraging DSS’s robust development, sales, and service infrastructure in the field of microscopy and digital imaging, CarbGeM will drive the deployment of AI solutions across medical and research institutions throughout India.
Established in 1998, DSS Imagetech Pvt. Ltd. is a leading Indian provider of advanced medical and research imaging solutions, headquartered in New Delhi with a strong nationwide presence. As an authorized partner of global brands such as Evident (formerly Olympus Scientific Solutions), Abbott, ADSTEC Corporation, Agilent Technologies (Dako), and through strategic collaborations including the DSS–Takara Bio Joint Venture with Takara Bio, Japan, DSS delivers high-performance microscopy, digital pathology, molecular diagnostics, AI-based solutions, and laboratory automation services to hospitals, research institutes, IVF centers, and pharmaceutical organizations across India.
With over 25 years of expertise, DSS combines world-class technology with strong technical support and customer-focused service.
Through this strategic partnership with DSS, CarbGeM will deliver innovative AI solutions that leverage image data from microscopes and various digital devices for both clinical and research applications.
This collaboration will further expand access to advanced AI solutions across India and other emerging markets, contributing to global efforts to combat antimicrobial resistance (AMR) and other life science challenges.
CarbGeM advances diagnostic support, research efficiency, and the standardization and automation of quality control in the life sciences sector through cutting-edge technologies, including regulatory approval for Software as a Medical Device (SaMD). By addressing challenges such as the shortage of skilled professionals and regional disparities, we deliver accurate and rapid results to support medical and industrial settings. Leveraging AI and digital platforms, we offer evidence-based decision-support solutions ranging from research-use AI to digital transformation (DX) for municipalities and industries. URL: https://carbgem.com/en/
